Procedural and Clinical Outcome after Low Speed Coronary Rotational Atherectomy

Procedural and Clinical Outcome after Low Speed Coronary Rotational Atherectomy - LS_CoRA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009868

Enrollment

180

Registered

2016-01-13

Start date

2016-02-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I20-I25

Interventions

Group 1: Procedural and clinical outcome in CAD patients after slow-speed rotablatory atherectomy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Treatment with Slow-Speed Rotablatory Atherectomy

Exclusion criteria

Exclusion criteria: no adequate German language skills to answer patient-reported questionnaires

Design outcomes

Primary

Measure	Time frame
Procedural outcome Angiographic success (Quantitative Coronary Angiography, TIMI-flow and myocardial blush prior and after intervention), procedural complications (dissection, perforation, slow flow/no flow, early stent thrombosis, myocardial infarction, cardiac and noncardiac death)	—

Secondary

Measure	Time frame
Clinical outcome up to 48 months: Adverse Events (repeated target and non-target vessel revascularisation – Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting), myocardial infarction; cardiac/non-cardiac death) Patient reported questionnaires for Health Related Quality of Life and Illness Perception (HeartQoL and BIPQ) at baseline, 6 months, 12 months and at the end of the follow-up period (24-48 months after index event).	—

Measure

Time frame

Clinical outcome up to 48 months: Adverse Events (repeated target and non-target vessel revascularisation – Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting), myocardial infarction; cardiac/non-cardiac death) Patient reported questionnaires for Health Related Quality of Life and Illness Perception (HeartQoL and BIPQ) at baseline, 6 months, 12 months and at the end of the follow-up period (24-48 months after index event).

—

Countries

Austria

Contacts

Public ContactOliver Friedrich

Karl Landsteiner Institut für Wissenschaftliche Forschung in der Klinischen Kardiologie

o.friedrich@karl-landsteiner.at+ 43 1 910 21-85211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026